Skip to main content

PEREGRINE CAPITAL MANAGEMENT LLC

Position in ADPT — Adaptive Biotechnologies Corp

CIK 764529 MINNEAPOLIS, MN

Position in ADPT

as of Mar 31, 2026 · filed Apr 23, 2026
Position Value
$6,754,577
-$594,055 QoQ
Shares Held
486,641
+7.5% QoQ
Ownership
0.304%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 36.90605600432352.ToString("F0")% Shared 0.ToString("F0")% None 63.09394399567648.ToString("F0")%

Common Shares in ADPT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

PEREGRINE CAPITAL MANAGEMENT LLC holds $21,809,084 across 3 Diagnostics & Research names. ADPT ranks #2 (31.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ADPT
Adaptive Biotechnologies Corp
This page
486,641 $6,754,577

All Filings in ADPT

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,754,577 486,641
2025-12-31 $7,348,632 452,502
2025-09-30 $7,821,117 522,802
2025-06-30 $8,186,583 702,711
2024-03-31 $1,206,048 375,716
2023-12-31 $1,840,626 375,638
2023-09-30 $2,397,754 439,955
2023-06-30 $3,135,489 467,286
2023-03-31 $4,127,097 467,395
2022-12-31 $2,044,700 267,631
2022-09-30 $1,984,564 278,731
2022-06-30 $2,378,079 293,953
2022-03-31 $4,415,852 318,145
2021-12-31 $9,525,275 339,461
2021-09-30 $9,426,888 277,343
2021-06-30 $13,153,692 321,921
2021-03-31 $11,445,636 284,293
2020-12-31 $17,550,138 296,806
2020-09-30 $15,913,194 327,230
2020-06-30 $18,048,013 373,047
2020-03-31 $10,711,690 385,590